MAOI or ECT? Patient Preference and Joint Decision-Making in Treatment-Resistant Depression View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-13

AUTHORS

Vincent Van den Eynde, Peter Kenneth Gillman

ABSTRACT

The literature concurs that the classic monoamine oxidase inhibitors (MAOIs) and electroconvulsive therapy (ECT) are both vital treatment options for ‘treatment-resistant’ depression (TRD)—but ECT is commonly presented as an option and MAOIs are not. This is a significant deficit in current psychiatric practice and constitutes a violation of the joint decision-making paradigm. The patient cannot choose between options the physician does not offer, thereby precluding meaningful patient participation in treatment selection. We emphasize the favorable side-effect profile of MAOIs when contrasted with ECT and argue that MAOI treatment should generally be considered as either a prior or alternative step in the treatment protocol for TRD. This is in line with the recommendations in the Dutch stepped- and shared-care approach to TRD, as expressed in their Standard of Care for Depressive Disorders. We conclude this line of reasoning by stating that the physician is morally obliged to both improve his/her understanding of the merits of MAOI treatment, and to pass this knowledge on to his/her patients. Only then is informed choice possible. More... »

PAGES

419-422

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40501-022-00277-z

DOI

http://dx.doi.org/10.1007/s40501-022-00277-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149443005


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "PsychoTropical Research, Queensland, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "PsychoTropical Research, Queensland, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Van den Eynde", 
        "givenName": "Vincent", 
        "id": "sg:person.014337547437.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014337547437.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "PsychoTropical Research, Queensland, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "PsychoTropical Research, Queensland, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gillman", 
        "givenName": "Peter Kenneth", 
        "id": "sg:person.0655266017.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655266017.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12910-015-0059-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043413860", 
          "https://doi.org/10.1186/s12910-015-0059-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2458-14-492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049819221", 
          "https://doi.org/10.1186/1471-2458-14-492"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-13", 
    "datePublishedReg": "2022-07-13", 
    "description": "Abstract\nThe literature concurs that the classic monoamine oxidase inhibitors (MAOIs) and electroconvulsive therapy (ECT) are both vital treatment options for \u2018treatment-resistant\u2019 depression (TRD)\u2014but ECT is commonly presented as an option and MAOIs are not. This is a significant deficit in current psychiatric practice and constitutes a violation of the joint decision-making paradigm. The patient cannot choose between options the physician does not offer, thereby precluding meaningful patient participation in treatment selection. We emphasize the favorable side-effect profile of MAOIs when contrasted with ECT and argue that MAOI treatment should generally be considered as either a prior or alternative step in the treatment protocol for TRD. This is in line with the recommendations in the Dutch stepped- and shared-care approach to TRD, as expressed in their Standard of Care for Depressive Disorders. We conclude this line of reasoning by stating that the physician is morally obliged to both improve his/her understanding of the merits of MAOI treatment, and to pass this knowledge on to his/her patients. Only then is informed choice possible.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40501-022-00277-z", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1049709", 
        "issn": [
          "2196-3061"
        ], 
        "name": "Current Treatment Options in Psychiatry", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "monoamine oxidase inhibitors", 
      "electroconvulsive therapy", 
      "MAOI treatment", 
      "favorable side effect profile", 
      "treatment-resistant depression", 
      "side effect profile", 
      "shared-care approach", 
      "standard of care", 
      "classic monoamine oxidase inhibitors", 
      "vital treatment option", 
      "current psychiatric practice", 
      "treatment options", 
      "patient preferences", 
      "depressive disorder", 
      "treatment protocol", 
      "patient participation", 
      "treatment selection", 
      "oxidase inhibitors", 
      "psychiatric practice", 
      "significant deficits", 
      "patients", 
      "physicians", 
      "depression", 
      "treatment", 
      "options", 
      "therapy", 
      "care", 
      "disorders", 
      "TRD", 
      "inhibitors", 
      "deficits", 
      "joints", 
      "recommendations", 
      "lines", 
      "protocol", 
      "decision-making paradigm", 
      "profile", 
      "practice", 
      "alternative steps", 
      "literature", 
      "participation", 
      "knowledge", 
      "standards", 
      "choice", 
      "understanding", 
      "preferences", 
      "paradigm", 
      "Dutch", 
      "selection", 
      "approach", 
      "step", 
      "violation", 
      "merits"
    ], 
    "name": "MAOI or ECT? Patient Preference and Joint Decision-Making in Treatment-Resistant Depression", 
    "pagination": "419-422", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149443005"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40501-022-00277-z"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40501-022-00277-z", 
      "https://app.dimensions.ai/details/publication/pub.1149443005"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_926.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40501-022-00277-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40501-022-00277-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40501-022-00277-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40501-022-00277-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40501-022-00277-z'


 

This table displays all metadata directly associated to this object as RDF triples.

124 TRIPLES      21 PREDICATES      79 URIs      69 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40501-022-00277-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Ncf38cd9a7bf04c5f93200cbde1cdf7fa
4 schema:citation sg:pub.10.1186/1471-2458-14-492
5 sg:pub.10.1186/s12910-015-0059-z
6 schema:datePublished 2022-07-13
7 schema:datePublishedReg 2022-07-13
8 schema:description Abstract The literature concurs that the classic monoamine oxidase inhibitors (MAOIs) and electroconvulsive therapy (ECT) are both vital treatment options for ‘treatment-resistant’ depression (TRD)—but ECT is commonly presented as an option and MAOIs are not. This is a significant deficit in current psychiatric practice and constitutes a violation of the joint decision-making paradigm. The patient cannot choose between options the physician does not offer, thereby precluding meaningful patient participation in treatment selection. We emphasize the favorable side-effect profile of MAOIs when contrasted with ECT and argue that MAOI treatment should generally be considered as either a prior or alternative step in the treatment protocol for TRD. This is in line with the recommendations in the Dutch stepped- and shared-care approach to TRD, as expressed in their Standard of Care for Depressive Disorders. We conclude this line of reasoning by stating that the physician is morally obliged to both improve his/her understanding of the merits of MAOI treatment, and to pass this knowledge on to his/her patients. Only then is informed choice possible.
9 schema:genre article
10 schema:isAccessibleForFree false
11 schema:isPartOf N49b2c7c05c524594833a81b65f191a05
12 N7d911cebd3194699a045629738832fec
13 sg:journal.1049709
14 schema:keywords Dutch
15 MAOI treatment
16 TRD
17 alternative steps
18 approach
19 care
20 choice
21 classic monoamine oxidase inhibitors
22 current psychiatric practice
23 decision-making paradigm
24 deficits
25 depression
26 depressive disorder
27 disorders
28 electroconvulsive therapy
29 favorable side effect profile
30 inhibitors
31 joints
32 knowledge
33 lines
34 literature
35 merits
36 monoamine oxidase inhibitors
37 options
38 oxidase inhibitors
39 paradigm
40 participation
41 patient participation
42 patient preferences
43 patients
44 physicians
45 practice
46 preferences
47 profile
48 protocol
49 psychiatric practice
50 recommendations
51 selection
52 shared-care approach
53 side effect profile
54 significant deficits
55 standard of care
56 standards
57 step
58 therapy
59 treatment
60 treatment options
61 treatment protocol
62 treatment selection
63 treatment-resistant depression
64 understanding
65 violation
66 vital treatment option
67 schema:name MAOI or ECT? Patient Preference and Joint Decision-Making in Treatment-Resistant Depression
68 schema:pagination 419-422
69 schema:productId N7bf3a83b12fb46a1a7c5a73b31c9eb2a
70 Ne140c67f677d47b7a7a2bed72620d0a8
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149443005
72 https://doi.org/10.1007/s40501-022-00277-z
73 schema:sdDatePublished 2022-12-01T06:43
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher N532e25d579d0427baf53ac81b5040143
76 schema:url https://doi.org/10.1007/s40501-022-00277-z
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N49b2c7c05c524594833a81b65f191a05 schema:issueNumber 4
81 rdf:type schema:PublicationIssue
82 N532e25d579d0427baf53ac81b5040143 schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 N7bf3a83b12fb46a1a7c5a73b31c9eb2a schema:name doi
85 schema:value 10.1007/s40501-022-00277-z
86 rdf:type schema:PropertyValue
87 N7d911cebd3194699a045629738832fec schema:volumeNumber 9
88 rdf:type schema:PublicationVolume
89 Nb2b817edf457444ca962b2c66541952b rdf:first sg:person.0655266017.83
90 rdf:rest rdf:nil
91 Ncf38cd9a7bf04c5f93200cbde1cdf7fa rdf:first sg:person.014337547437.40
92 rdf:rest Nb2b817edf457444ca962b2c66541952b
93 Ne140c67f677d47b7a7a2bed72620d0a8 schema:name dimensions_id
94 schema:value pub.1149443005
95 rdf:type schema:PropertyValue
96 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
97 schema:name Medical and Health Sciences
98 rdf:type schema:DefinedTerm
99 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
100 schema:name Clinical Sciences
101 rdf:type schema:DefinedTerm
102 sg:journal.1049709 schema:issn 2196-3061
103 schema:name Current Treatment Options in Psychiatry
104 schema:publisher Springer Nature
105 rdf:type schema:Periodical
106 sg:person.014337547437.40 schema:affiliation grid-institutes:None
107 schema:familyName Van den Eynde
108 schema:givenName Vincent
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014337547437.40
110 rdf:type schema:Person
111 sg:person.0655266017.83 schema:affiliation grid-institutes:None
112 schema:familyName Gillman
113 schema:givenName Peter Kenneth
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655266017.83
115 rdf:type schema:Person
116 sg:pub.10.1186/1471-2458-14-492 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049819221
117 https://doi.org/10.1186/1471-2458-14-492
118 rdf:type schema:CreativeWork
119 sg:pub.10.1186/s12910-015-0059-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1043413860
120 https://doi.org/10.1186/s12910-015-0059-z
121 rdf:type schema:CreativeWork
122 grid-institutes:None schema:alternateName PsychoTropical Research, Queensland, Australia
123 schema:name PsychoTropical Research, Queensland, Australia
124 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...